Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Viewpoint Oct 2015 Deciding Whether To Refer a Colleague to a Physician Health Program J. Wesley Boyd, MD, PhD AMA J Ethics. 2015;888-893. doi: 10.1001/journalofethics.2015.17.10.spec1-1510. Policy Forum Nov 2021 How Medicaid and States Could Better Meet Health Needs of Persons Experiencing Homelessness Sana Charania Access to shelter can improve health outcomes for individuals experiencing homelessness and reduce overall health costs. AMA J Ethics. 2021;23(11):E875-880. doi: 10.1001/amajethics.2021.875. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Art of Medicine Sep 2020 Data, Decisions, White Coats Christine Lynn Chen This pen and ink drawing reimagines a white coat in the context of medicine’s realistic, not idealized, dynamism. AMA J Ethics. 2020;22(9):E818-820. doi: 10.1001/amajethics.2020.818. Art of Medicine Oct 2019 What Historical Ideals of Women’s Shapes Teach Us About Women’s Self-Perception and Body Decisions Today Nealie Tan Ngo The Body Issue is a graphic memoir exploring cultural and social influences on women’s self-conception and decisions. AMA J Ethics. 2019;21(10):E879-901. doi: 10.1001/amajethics.2019.879. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Viewpoint Oct 2015 Deciding Whether To Refer a Colleague to a Physician Health Program J. Wesley Boyd, MD, PhD AMA J Ethics. 2015;888-893. doi: 10.1001/journalofethics.2015.17.10.spec1-1510.
Policy Forum Nov 2021 How Medicaid and States Could Better Meet Health Needs of Persons Experiencing Homelessness Sana Charania Access to shelter can improve health outcomes for individuals experiencing homelessness and reduce overall health costs. AMA J Ethics. 2021;23(11):E875-880. doi: 10.1001/amajethics.2021.875.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Art of Medicine Sep 2020 Data, Decisions, White Coats Christine Lynn Chen This pen and ink drawing reimagines a white coat in the context of medicine’s realistic, not idealized, dynamism. AMA J Ethics. 2020;22(9):E818-820. doi: 10.1001/amajethics.2020.818.
Art of Medicine Oct 2019 What Historical Ideals of Women’s Shapes Teach Us About Women’s Self-Perception and Body Decisions Today Nealie Tan Ngo The Body Issue is a graphic memoir exploring cultural and social influences on women’s self-conception and decisions. AMA J Ethics. 2019;21(10):E879-901. doi: 10.1001/amajethics.2019.879.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.